01.05.2014 Views

2012 Annual Report - Hong Kong Monetary Authority

2012 Annual Report - Hong Kong Monetary Authority

2012 Annual Report - Hong Kong Monetary Authority

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ANZ ANNUAL REPORT <strong>2012</strong><br />

1 The maximum value at the time of the grant is determined by multiplying the number<br />

granted by the fair value of the equity instruments. The minimum value of the grants, if<br />

the applicable conditions are not met at vesting date, is nil. Options/rights granted include<br />

those granted as remuneration to the five highest paid executives in the Company and<br />

the Group (being the five highest paid, relevant Group and Company executives who<br />

participate in making decisions that affect the whole, or a substantial part, of the business<br />

of the Company or who have the capacity to significantly affect the Company’s financial<br />

standing). No options/rights have been granted since the end of <strong>2012</strong> up to the signing of<br />

the Director’s <strong>Report</strong> on 5 November <strong>2012</strong>.<br />

2 The value of shares and/or share rights and/or performance rights is based on the one<br />

day VWAP of the Company’s shares traded on the ASX on the date of vesting, lapsing or<br />

exercising, multiplied by the number of shares and/or share rights and/or performance<br />

rights. The value of options is based on the difference between the one day VWAP and the<br />

exercise price, multiplied by the number of options.<br />

3 For KMP who ceased employment during <strong>2012</strong>, the number of equity instruments “Vested<br />

and exercisable” are as at their date of cessation.<br />

4 D Hisco – Hurdled options granted 5 November 2004 were exercised on 4 November 2011.<br />

One day VWAP on date of exercise was $20.9933. The exercise price was $20.68. STI deferred<br />

share rights granted 12 November 2010 were exercised on 14 November 2011. One day<br />

VWAP on date of exercise was $20.8876.<br />

5 G Hodges – Hurdled options granted 5 November 2004 were exercised on 4 November<br />

2011. One day VWAP on date of exercise was $20.9933. The exercise price was $20.68. LTI<br />

performance rights granted 31 October 2008 were exercised on 9 November 2011. One day<br />

VWAP on date of exercise was $21.8346.<br />

6 J Phillips – was appointed to the CEO Global Wealth & Private Banking role on 1 March <strong>2012</strong><br />

and no equity transactions were applicable for the period.<br />

7 A Thursby – LTI performance rights granted 31 October 2008 were exercised on 4 November<br />

2011. One day VWAP on date of exercise was $20.9933.<br />

8 N Williams – was appointed to the Chief Risk Officer role on 17 December 2011 and no<br />

equity transactions were applicable for the period.<br />

9 P Marriott – ceased employment 31 August <strong>2012</strong> so equity transactions are to that date.<br />

Transactions include those that transpired prior to cessation and those that were forfeited<br />

on cessation. Hurdled options granted 5 November 2004 were exercised on 4 November<br />

2011. One day VWAP on date of exercise was $20.9933. The exercise price was $20.68. STI<br />

deferred options granted 31 October 2008 were exercised on 11 May <strong>2012</strong>. One day VWAP<br />

on date of exercise was $22.0692. The exercise price was $17.18. LTI performance rights<br />

granted 31 October 2008 were exercised on 10 November 2011. One day VWAP on date of<br />

exercise was $20.6017.<br />

10 C Page – retired 16 December 2011 so equity transactions are to that date. Transactions<br />

include those that transpired prior to cessation and those that were forfeited on cessation.<br />

Treatment of equity on retirement is in line with treatment of equity on redundancy. LTI<br />

performance rights granted 31 October 2008 were exercised on 14 November 2011. One day<br />

VWAP on date of exercise was $20.8876. Due to cessation, 11,452 LTI deferred shares granted<br />

12 November 2010 were forfeited and processed by Computershare on 20 December 2011.<br />

11 The Disclosed Executives had a proportion of their STI amount deferred as equity. In <strong>2012</strong> D<br />

Hisco received share rights rather than shares due to taxation regulations in New Zealand.<br />

A share right effectively provides a right in the future to acquire a share in ANZ at nil cost<br />

to the employee. Refer to the STI arrangements section for further details of the mandatory<br />

deferral arrangements for the Disclosed Executives and Tables 8 and 9 for details of the<br />

valuation methodology, inputs and fair value.<br />

12 The 2011 LTI grants for Disclosed Executives were delivered as performance rights excluding<br />

for the CRO. Refer to section 6.2.2 LTI Arrangements for further details and Table 8 for details<br />

of the valuation, inputs and fair value.<br />

Disclosed Executives’ Contract Terms<br />

The following sets out details of the contract terms relating to the Disclosed Executives. The contract terms for all Disclosed Executives are<br />

similar, but do on occasion, vary to suit different needs.<br />

Length of contract<br />

Notice periods<br />

Resignation<br />

Termination on<br />

notice by ANZ<br />

Redundancy<br />

Disclosed Executives are on a permanent contract, which is an ongoing employment contract until notice is given<br />

by either party.<br />

In order to terminate the employment arrangements, Disclosed Executives are required to provide the Company<br />

with six months’ written notice. ANZ must provide Disclosed Executives with 12 months’ written notice.<br />

On resignation, unless the Board determines otherwise, all unvested deferred shares, all unvested or vested but<br />

unexercised performance rights, all options and all deferred share rights are forfeited.<br />

ANZ may terminate the Disclosed Executive’s employment by providing 12 months’ written notice or payment<br />

in lieu of the notice period based on fixed remuneration. On termination on notice by ANZ, unless the Board<br />

determines otherwise:<br />

all unvested deferred shares, performance rights, options and deferred share rights are forfeited at the time notice<br />

is given to the Disclosed Executive; and<br />

only performance rights, options and deferred share rights that are vested may be exercised.<br />

If ANZ terminates employment for reasons of redundancy, a severance payment will be made that is equal to<br />

12 months’ fixed remuneration.<br />

All STI deferred shares and STI deferred share rights remain subject to clawback and are released at the original<br />

vesting date. Options, performance rights, LTI deferred shares and LTI deferred share rights are either released in<br />

full or on a pro-rata basis, at the discretion of the Board with regard to the circumstances.<br />

Death or total and<br />

permanent disablement<br />

Termination for<br />

serious misconduct<br />

Statutory Entitlements<br />

Other arrangements<br />

On death or total and permanent disablement all unvested STI deferred shares, all deferred share rights, performance<br />

rights and all options will vest.<br />

ANZ may immediately terminate the Disclosed Executive’s employment at any time in the case of serious misconduct,<br />

and the employee will only be entitled to payment of fixed remuneration up to the date of termination.<br />

On termination without notice by ANZ in the event of serious misconduct any options, performance rights, deferred<br />

shares and deferred share rights still held in trust will be forfeited.<br />

Payment of statutory entitlements of long service leave and annual leave applies in all events of separation.<br />

P Chronican<br />

As Mr Chronican joined ANZ in November 2009 he was not included in the LTI grants made to other Management<br />

Board members in early November 2009. Accordingly, a separate LTI grant was made in December 2009 providing<br />

performance rights on the same terms and conditions as those provided to Management Board for 2009, apart from<br />

the allocation value which varied to reflect the different values at the respective grant dates.<br />

A Thursby<br />

As part of Mr Thursby’s employment arrangement, he was granted three separate tranches of deferred shares to the<br />

value of $1 million per annum, subject to Board approval. The first tranche was granted in September 2007 and vested<br />

in September 2010, the second tranche was granted in August 2008 and vested in August 2011, and the third tranche<br />

was granted in September 2009 and vested in September <strong>2012</strong>.<br />

REMUNERATION REPORT 29

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!